JANICE NICOLE CORMIER to Antigens, Neoplasm
This is a "connection" page, showing publications JANICE NICOLE CORMIER has written about Antigens, Neoplasm.
Connection Strength
0.366
-
Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. J Immunother. 1998 Jan; 21(1):27-31.
Score: 0.093
-
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J Sci Am. 1997 Jan-Feb; 3(1):37-44.
Score: 0.087
-
Immune selection after antigen-specific immunotherapy of melanoma. Surgery. 1999 Aug; 126(2):112-20.
Score: 0.026
-
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model. Int J Cancer. 1999 Mar 01; 80(5):781-90.
Score: 0.025
-
Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy. J Immunol. 1998 Jul 15; 161(2):877-89.
Score: 0.024
-
Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer. 1998 Feb 09; 75(4):517-24.
Score: 0.023
-
Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity. Ann Surg Oncol. 1998 Jan-Feb; 5(1):64-76.
Score: 0.023
-
Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro. J Immunother. 1997 Jul; 20(4):276-86.
Score: 0.022
-
Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. J Immunother. 1997 Jan; 20(1):60-4.
Score: 0.022
-
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol. 1996 May; 19(3):192-205.
Score: 0.021